KLAS: Providers demand, but are slow to deploy EMR-integrated smart pumps

More than half of U.S. healthcare providers consider EMR integration a key factor in selecting smart-pump vendors and products—but the number of providers who are actually integrating their smart pumps is in the single digits.

So said KLAS in announcing the results of a new survey, which also found that only 60 percent of 218 provider organizations surveyed are live on wireless technology despite the fact that it is required for EMR integration.

Report author Coray Tate, the healthcare research firm’s vice president of clinical research, said 23 percent of respondents reported serious medication incidents in the past 24 months and 60 percent of those were made while using drug libraries. EMR integration with automatic programming would help eliminate those types of programming errors.

Respondents favored vendors established in the market over those still getting started with wireless smart pumps. KLAS said those using wireless pumps were much more likely to be using smart pump report data and monitoring drug library compliance.

CareFusion and Hospira, followed closely by Baxter, are the leaders in delivering wireless functionality and EMR integration, according to the report. Providers’ greatest frustration is waiting on the delivery of these features.

“Without wireless you don’t know what you don’t know,” said Tate. “You are essentially static and your ability to adjust your libraries and processes is greatly reduced. Getting to wireless is an important step in safer infusions.”

Dave Pearson

Dave P. has worked in journalism, marketing and public relations for more than 30 years, frequently concentrating on hospitals, healthcare technology and Catholic communications. He has also specialized in fundraising communications, ghostwriting for CEOs of local, national and global charities, nonprofits and foundations.

Around the web

CMS finalized a significant policy change when it increased the Medicare payments hospitals receive for performing CCTA exams. What, exactly, does the update mean for cardiologists, billing specialists and other hospital employees?

Stryker, a global medtech company based out of Michigan, has kicked off 2025 with a bit of excitement. The company says Inari’s peripheral vascular portfolio is highly complementary to its own neurovascular portfolio.

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.